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INTRODUCTION 
The potato virus Y group is a very large group of plant viruses which 
is responsible for significant yield reductions in many commercially 
important crops. All of these viruses are transmitted in a nonpersistent 
manner by aphids, and many are also transmitted in seed. Control of virus 
infection for the seed-borne viruses is effectively accomplished by 
the planting of virus-free seeds. The routine monitoring of seed lots for 
viral infection requires a reliable and cost effective indexing method, and 
although a variety of assay methods are available, immunoassay procedures 
are probably the most sensitive and economical. 
Previous work involving the development of immunoassays for plant 
viruses has demonstrated that obtaining antibodies with no cross reaction 
to healthy plant tissue can be difficult. Various immunopurification 
procedures can be used; however, these are time consuming and often expen­
sive. One way to avoid problems involving cross reaction is to use 
monoclonal antibodies for the development of the assays. These antibodies 
are produced using somatic cell hybridization techniques, and they are 
specific for antigenic determinants on the virus particles. 
Although monoclonal antibodies have been widely applied in the field 
of animal virology, this work represents one of the first attempts to 
utilize them in the field of plant virology. The project involved the 
development of monoclonal antibodies to members of the potato virus Y 
group, responsible for infection and yield reductions in corn, soybeans, 
lettuce, sugarcane, and sorghum. The monoclonal antibodies were then used 
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for the development of immunoassays and investigated for potential use in 
virus purification. 
3 
LITERATURE REVIEW 
Plant Virus Infection 
Soybean mosaic virus (SMV), lettuce mosaic virus (LMV), maize dwarf 
mosaic virus A (MDMV-A), and maize dwarf mosaic virus B (MDMV-B, also known 
as sugarcane mosaic virus) were the plant viruses used in this study. All 
of these viruses are members of the largest group of plant viruses, the 
potato virus Y group. This is a commercially important group of plant 
viruses with about 73 members (57). Members of the potato virus Y group 
are long flexuous rods measuring 680-900 x 11 nm (44, 57). Their capsids 
consist of multiple copies of a single type of capsid protein having a 
molecular weight of 28-36,000 (57, 61, 64). A single stranded, positive 
(sense), RNA genome is present that has a molecular weight of 2.8-3.5 
million daltons (57, 62, 64). During infection, the potato virus Y group 
induces the formation of pinwheel inclusions in infected cells (?6, 40, 44, 
103). These inclusions are unique to the potato virus Y group and are use­
ful for the diagnosis of infection at the group level (40, 57). A further 
division of the group can also be made based on inclusion structure. 
Subdivision I viruses produce scroll-like inclusions, subdivision II 
viruses produce laminated aggregates, and subdivision III viruses produce 
both scroll and laminated aggregate inclusions (40). 
The viruses used in this work represent all three subdivisions of the 
potato virus Y group. They infect the commercially important crops, corn, 
lettuce, soybean, sugarcane, and sorghum. The extent of the diseases can 
be rather varied and depends on a number of variables including the virus 
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strain (58, 123, 124, 134), the cultivar planted (87, 110), the age of the 
plants at Infection (122, 126), and environmental factors (24, 39). Many 
physical and chemical changes can accompany the infection such as changes 
in amino acid, starch, and lipid concentrations (55, 92, 108), delayed 
maturity (36, 49), stunting (40), reduction in seed germination (60), and 
reduction in seed quantity and quality (66, 78). Depending on virus, host, 
and vector relationships, all of the viruses used in this work can be 
responsible for significant yield reductions (40, 118, 119, 125). LMV in 
the presence of active vector transport has been shown to cause total crop 
loss (109). SMV can reduce yields by 20% or more (5) and may affect nodu-
lation and nitrogen fixation (136). MDMV-A has been reported to cause 
yield reductions of up to 32% for corn (74) , and MDMV-B reduces the yield 
of corn, sugarcane, and sorghum (1, 35, 73). 
All of the potato virus Y group are mechanically transmissable 
although that is probably of minor importance in the field (40) . The most 
important factor in the spread of most of these viruses is transmission by 
vectors. Aphids are very efficient transmitters of potato virus Y group 
members. These viruses are transmitted in a nonpersistent manner, being 
transported on the tips of aphid stylets. Virus is not absorbed or trans­
located in the aphid (40). Aphids can acquire the virus from an infected 
plant and transmit it to a healthy plant in as little as 20 seconds (97) 
and can remain viruliferous for many hours. Due to the stylet borne mode 
of transmission, the potato virus Y group has a low level of vector speci­
ficity and can be transmitted by many different aphid species. It has been 
reported that SMV can be transmitted by at least 20 species of aphid (3). 
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MDMV-B, which is primarily transmitted by aphids, has also been shown to be 
transmitted through soil, although the soil inhabiting vectors have not been 
identified (11). Virus may also be transmitted by vegetative propagation 
in crops such as sugarcane. 
Some members of the potato virus Y group, including SMV (30) and LMV 
(33), are seed transmitted. MDMV-B has also been reported to have a low 
level of seed transmission in corn (128), whereas MDMV-A is not transmitted 
through seed. Seed transmission is an effective method for virus survival 
and overwintering, and it is an important factor in the establishment of 
virus infection (40). Infected seed serves an important role as an initial 
inoculum (65), providing an early source of virus for vectors. The primary 
foci developed from infected seeds undergoes secondary spread by aphid 
vectors leading to the significant levels of infection seen by the end of a 
season (65, 66). 
Control of virus infection can be accomplished in a variety of ways. 
The best way is to develop plants resistant or tolerant to viral infection. 
These plants are developed by combining resistance and tolerance traits 
with acceptable growth and yield characteristics. A great amount of time 
and effort, however, is involved in the development of resistant or toler­
ant plants, and sometimes tolerant plants are not an acceptable solution 
because they can act as a reservoir for the spread of virus to other hosts 
(98). Control of vectors is another possible way to limit virus spread. 
This generally involves the use of insecticides for aphid vectors. Insec­
ticide control, however, is not very successful with nonpersistently 
transmitted viruses such as the potato virus Y group because incoming 
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aphids can transmit the virus before being killed by the insecticide (25). 
Some investigators have reported that nonpersistent transmission can be 
reduced using oil treatments; however, that method is expensive and short­
lived . 
One of the best methods for controlling the spread of seed transmitted 
virus is to reduce the primary inoculum by reducing the number of infected 
seeds planted. One way to do this is to develop varieties that will not 
transmit virus through their seed (53) , but that involves extensive time and 
effort and may be unsuccessful (88). The most feasible way is to check 
seed for the presence of virus and plant only virus-free seed (53, 135) or 
seed containing low enough levels of virus to ensure practically virus-free 
crops until the later stages of growth (135). 
Various methods have been used for the detection of virus in seed with 
probably the simplest being the visual inspection of seed. In some cases, 
there is a strong correlation between seed morphology and viral infection 
(115), but in most cases, the relationship is inconsistent (32). One of 
the most reliable ways to detect infected seed is to use biological assays 
Seeds may either be grown up and the plants examined for the presence of 
virus symptoms or seed extracts may be inoculated onto highly susceptible 
plants (116) or detached leaves (104) which are then observed for the 
development of symptoms. Such biological assays have been successfully 
used in California for monitoring lettuce seed for the presence of LMV 
(40). The main drawbacks to the biological assays are the considerable 
time and space requirements which make these assays very expensive for 
screening large numbers of seed lots on a routine basis. The problems 
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inherent to the biological assays can be avoided through the use of various 
immunological assays. These assays have the potential for very high sensi­
tivity and specificity iind arc generally very rapid. 
Immunological assay methods that have been used for the detection of 
virus in seeds include passive hemagglutination (4), microprecipitin (8), 
latex agglutination (52), bentonite flocculation (13), complement fixation 
(52), and gel diffusion. Gel diffusion has been one of the more popular 
techniques, and it has been the basis of several commercial screening 
programs (34). One problem associated with gel diffusion techniques, how­
ever, is that nonisometric viruses, such as the potato virus Y group, must 
be degraded to diffusable protein subunits before testing (20, 65). Even 
greater sensitivity can be obtained through the use of other immunological 
techniques such as immune electron microscopy (IBM), enzyme linked immuno­
sorbent assay (ELISA), and radioimmunosorbentassay (RIA). lEM involves 
the attachment of virus particles to an electron microscope grid that has 
previously been coated with specific antibody. lEM has been used to 
develop assays for potato virus Y (37), LMV (14), SMV (15), and other 
viruses. These assays are much more sensitive than gel diffusion assays 
and in some instances more sensitive than immunosorbent assays. Although 
IEM assays are very sensitive, they require considerable training, expen­
sive equipment, and are time consuming. Therefore, they are not 
well-suited to routine analysis of a large number of samples. The immuno­
sorbent assays have received a lot of attention in recent years and have 
proved to be very versatile assays for the specific detection and sensitive 
quantitation of a wide variety of antigenic substances. Immunosorbent 
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techniques have been successfully used for the detection of plant viruses 
in both radioimmunoassay (51, 68) and enzyme linked immunoassay systems 
(12, 70, 95, 132). These systems combine good sensitivity with rapid 
processing ability and are now the method of choice for the detection of 
plant viruses. 
Immunoassays 
Immunosorbent assays were first developed as radioimmunological 
systems combining the specificity of antibodies with the sensitivity for 
detection of radioisotopes. The first radioimmunoassay was developed by 
Yallow and Berson (146) for the detection of insulin. Various types of 
radioimmunoassays in use today are modifications or adaptations of this 
assay. It was based on the ability of the sample antigen to compete with 
labeled antigen for binding to a limited number of antibody molecules. 
Initially radioimmunoassays were designed such that all of the reagents 
were in soluble form. Those types of assays required some method for the 
separation of antibody bound from unbound reagents. Various physical and 
chemical methods (77, 80) as well as immunological methods (16, 45, 105) 
can be used. Although these produce sensitive assays, they require time 
consuming centrifugation or filtration procedures for complete separation. 
Radioimmunoassay systems were greatly simplified by the introduction 
of solid phase supports, which immobilize reagents to a solid surface. 
Separation of bound and unbound reagents is then accomplished by washing 
the solid phase support. Immobilization of antigen or antibody to the 
solid phase must be done in such a way that antigenicity or immunological 
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activity are maintained. Protein antigens and immunoglobulins can be immo­
bilized by passive adsorption (23). This type of binding to the solid 
phase is based on the discovery of Leininger et al. (93) that proteins will 
hydrophobically interact with and nonspecifically bind to plastic surfaces. 
Proteins as well as other types of molecules can also be covalently 
attached to the solid phase support using chemical coupling agents (21, 29, 
38). A wide variety of materials such as polystyrene, polyvinyl, poly­
propylene, microcrystalline glass, silicone rubber, polyacrylamide, and 
various polysaccarides have been used as solid phase supports in the form 
of beads (56, 76, 149), disks (22, 140, 142), tubes (8, 23, 94), and plates 
(75, 91, 117). 
The introduction of solid phase methodology has stimulated the design 
of assays such as the double antibody sandwich, the inhibition assay, and 
the indirect assay. These assays provide a great deal of versatility for 
the monitoring of both antibody and antigen, and they can be used for a 
wide range of biological substances (144). 
The radioisotopes most often used in radioimmunoassay are the iodine 
125 131 isotopes I and I. These isotopes are used because their gamma radia­
tion is not easily quenched, compounds may be easily iodinated, the 
iodinated products are stable, and the specific activity is high. Problems 
associated with the use of iodine include potential inactivation of immuno­
logical activity due to iodination of tyrosine in the active site (72), 
short storage times due to the short half-lives, and strict safety regula­
tions. These problems can be avoided by using other radioisotopes such as 
14 35 3 C, S, and H (71, 101, 145). Tritium has been used to label a variety 
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of biological compounds, including immunoglobulins, and it lacks most of 
the disadvantages associated with iodine. In vitro labeling with tritium 
is easy to perform and generally results in little or no loss of biological 
activity (31, 81, 150). Its longer half-life allows for extended storage 
and long-term use of the same lot for increased reproducibility. Its main 
disadvantage is the lower specific activity obtained. 
Immunosorbent assays using an enzyme label in place of the isotope 
label are called enzyme linked immunosorbent assays. These assays were 
developed as alternatives to the well-established radioimmunoassays by 
van Weemen and Schuurs (139) and Engvall and Perlmann (41). Enzyme immuno­
assays were derived from enzyme labeled histologic techniques combined with 
principles developed for radioimmunoassay. The many variations possible 
with radioimmunoassay are generally applicable to enzyme immunoassays. 
Advantages of an enzyme label include economical preparation, long shelf 
life, freedom from radiological safety procedures, and results which can be 
determined visually or with simple inexpensive equipment. The enzymes used 
must be stable, inexpensive, easy to purify, available in quantity, have a 
high turnover rate, be absent from sample fluids, have stable, soluble 
chromogenic substrates, and be able to conjugate to antibodies with reten­
tion of activity. Enzymes which meet these criteria and are frequently 
used are alkaline phosphatase, horseradish peroxidase, and galactosidase. 
Conjugation is generally performed using heterofunctional cross-linking 
agents such as glutaraldehyde (6, 7). 
Other improvements in the development of immunoassay technology have 
been described, and they include the use of fluorescent substrates (85, 
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148), chemiluminescent labels (129), radioactive substrates (59) , and 
biotin-avidin linked systems. The improvement of sensitivity and speci­
ficity through the use of monoclonal antibodies has also been investigated. 
The development of both enzymatic and isotopic immunoassays for the 
detection of plant virus has proceeded at a rapid rate, and there are now 
assays available for a wide variety of plant viruses (9, 54, 69, 107). 
Previous work performed by the research group that I was associated with 
(Bryant, Hill, and Durand) concerned the development of immunoassays for 
the detection of soybean mosaic virus. A double antibody sandwich radio­
immunoassay using a tritium label was developed which was capable of 
detecting 25 nanograms of SMV in ground soybean seed (17). This assay was 
modified to an ELISA assay using alkaline phosphatase conjugated by a one-
step gluteraldehyde reaction (7). The ELISA assay proved to be even more 
sensitive with a detection limit of 5 nanograms, but the dose response 
curve was not as accurate for quantitative purposes (63). 
Antibody used for the SMV assays was generated in rabbits, and prob­
lems were encountered with cross reaction to healthy soybean tissue. Even 
when the ammonium sulfate precipitated antibody fraction was cross absorbed 
against healthy soybean tissue, the problem of cross reaction and subse­
quent false positives persisted. In order to get around the cross reaction 
problem, an immunopurification scheme was used (100). This consisted of 
adding purified virus to the antibody fraction, followed by separation of 
the virus-antibody immune complex from unbound antibody by centrifugation. 
Precipitated immune complexes were then dissociated at pH 3.0, and the 
virus specific antibody was separated from whole virus particles by sucrose 
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gradient centrifugation. Although this procedure was successful in the 
elimination of cross reactivity, it was very time consuming and not well-
suited for routine analysis of seed lots. 
The research group then decided to investigate the use of monoclonal 
antibodies for the SMV immunoassay. It was reasoned that monoclonal anti­
bodies would be free from cross reaction problems and could be used in the 
assay without immunopurification. Monoclonal antibodies could also pro­
vide better reproducibility, and they have the potential for better 
sensitivity and specificity. Development of monoclonal antibodies to SMV 
and other members of the potato virus Y group might also point out serolog­
ical relationships not detected using conventional antiserum. Although 
monoclonals have been widely applied in the field of animal virology (46, 
86, 147), this work represents one of the first attempts to utilize them in 
the field of plant virology. 
Monoclonal Antibodies 
Conventional antiserum usually used in immunoassays is collected from 
hyperimmunized animals and is a very heterogeneous polyclonal product. 
Most antigens contain several antigenic sites so the antiserum will contain 
antibodies specific for each antigenic site and antibodies with differing 
avidities for the same antigenic site. As a result, the affinity, avidity 
and cross reactivity of antiserum are due to a combined effect of all the 
antibodies present. This is further complicated bv he fact that each 
animal injected responds with its own unique se' antibodies. Thus, 
pooled antiserum is a very complex mixture of antibodies with significant 
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lot to lot variations. The affinity and cross reactivity of pooled anti­
serum can be manipulated using cross absorption and immunopurification 
techniques; however, this is often tedious, generally results- in lower 
titer, and still results in a heterogeneous product. 
The clonal selection theory developed by Burnet (18) first introduced 
the concept of homogeneous or monoclonal antibodies. According to this 
theory, an antibody secreting plasma cell produces only one type of anti­
body in response to one particular antigenic determinant. All the plasma 
cells producing this particular antibody are descendants from one B-lympho-
cyte clone. In an animal, even one antigenic determinant will stimulate 
multiple B-cell clones; however, if one of these B-cell clones could be 
isolated and grown in culture, the result would be a homogeneous antibody 
derived from a single clone, i.e. a monoclonal antibody. 
Attempts to clone and grow B-cells isolated from peripheral blood or 
the spleen have not proved very successful. Some investigators (50, 102) 
have reported the production of nanogram quantities of monoclonal anti­
bodies using this procedure, but the B-cells do not grow and the cultures 
die after a few weeks. Transformation of B-cells to increase growth poten­
tial has been attempted using Epstein Barr virus (43), simian virus 40 
(131), Abelson virus (2), and various chemical agents. Cell lines have been 
established by transformation; however, only small quantities of antibody 
are secreted, and it is difficult to get antibody for a specific antigen 
(147). Somatic cell hybridization studies between B-lymphocytes and other 
cells such as fibroblasts also produced stable cell lines, but antibody 
synthesis is suppressed (28, 112). 
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Another approach to the development of monoclonals is the use of 
myelomas. Myelomas are cancers of the antibody producing system, and each 
tumor is derived from a single B-cell clone. Antibody is secreted by the 
tumor in large quantity, and it is a source of monoclonal antibody. These 
tumors have been adapted for growth in culture (67, 114), and the anti­
bodies produced have been used extensively for the study of immunoglobulin 
structure (90, 99, 106). Myelomas can be induced in mice by injection of 
mineral oil, and unsuccessful attempts have been made to induce antigen 
specific myelomas in hyperimmunized animals. 
One of the first mouse myeloma tumors to be adapted for growth in 
culture was the mineral oil induced plasmacytoma designated MOPC-2]. (67). 
This cell line was called P3 and was extensively used in mutagenesis experi­
ments and to study antibody synthesis. Somatic cell hybridization studies 
were also undertaken with the myeloma cells, and it was found that plasma­
cytoma-fibroblast hybrids lost antibody production (28), whereas plasma­
cytoma-plasmacytoma hybrids maintained antibody production. Further work 
by Milstein resulted in the development of an 8-azaguanine resistant line 
of P3 which he termed P3/X63-Ag 8. When this cell line was hybridized to 
another antibody producing plasmacytoma, the hybrid produced the antibody 
molecules from both parents. This result lead KBhler and Milstein (82) to 
try a fusion between the myeloma cells and mouse spleen cells that had been 
immunized against sheep red blood cells. The hybrid produced both the 
myeloma antibody and antibody specific for sheep red blood cells. KGhler 
and Milstein repeated this experiment first with sheep red blood cells and 
later with the trinitrophenyl hapten (83) to confirm that their procedure 
15 
could produce cell lines secreting antibody to a specific antigen. The 
development of this procedure allows the specific antibody production of 
B-lymphocytes to be linked to the growth potential of myeloma cells. 
The use of the P3/X63-Ag 8 myelomas in cell fusion experiments with 
lymphocytes resulted in the production of myeloma antibody, lymphocyte 
specific antibody, and mixed antibody containing all possible combinations 
of myeloma and lymphocyte heavy and light chains. This mixture of anti­
bodies can lead to confusing results when antibody analysis is performed 
(84). Previous work with myelomas had demonstrated a high rate of mutation 
for immunoglobulin synthesis and secretion (27). This lead investigators 
to look for myelomas that did not secrete or produce immunoglobulin. These 
myelomas would be better partners for fusion with lymphocytes because only 
the lymphocyte antibody would be produced. A nonsecreting variant of the 
P3/X63-Ag 8 cell line was isolated which produced but did not secrete the 
kappa light chain (84). This cell line was termed NSI/l.Ag 4.1, and it is 
widely used for cell fusions; however, the resulting antibody can still 
contain myeloma light chain. A myeloma line that does not produce any 
immunoglobulin was developed by Schulman et al. (127) by selection after a 
cell fusion between P3/X63-Ag 8 and spleen lymphocytes. This cell line is 
called Sp2/0-Ag 14, and hybrids developed using this myeloma produce only 
the lymphocyte specific antibody. All of the myeloma lines mentioned to 
this point were derived from Balb/C mice, and the cell hybridizations are 
best performed with Balb/C spleens; however, if Balb/C mice do not respond 
well to the antigen used, other strains of mice can be used. Myelomas 
derived from LOU rats and designated Y3-Ag 1.2.3 and YB2/3.0 Ag 20 have 
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been developed for use in a rat monoclonal system. Some workers have fused 
mouse myelomas with rabbit or human spleen cells; however, the hybrid cells 
are very unstable and generally lose antibody production. There has been 
considerable interest in developing human myeloma cell lines for the devel­
opment of human monoclonals, and although there has been some success 
reported, there are at present no human lines available for widespread 
distribution. 
Regardless of which myeloma cell line is used, the general procedure 
for the development of monoclonal antibodies is basically the same as 
originally outlined by KGhler and Milstein (82). Animals are immunized with 
the antigen of interest and then hyperimmunized after about one month. The 
exact immunization schedule has to be worked out with each antigen by moni­
toring the immunological response. Spleens, bone marrow, or lymph nodes 
are removed when the maximum number of antibody producing B-cells are 
present, which usually is three to four days after hyperimmunization (10). 
A single cell suspension is produced, mixed with myeloma cells, and the two 
cell types are fused. The suspension of fused cells is then divided into 
numerous isolated cultures. KShler and Milstein's original work called for 
fusing cells using inactivated Sendai virus, but most workers now fuse cells 
using polyethylene glycol (47). During the fusion process, the myeloma 
cells and spleen cells fuse in all possible combinations resulting in 
myeloma-myeloma hybrids, spleen-spleen hybrids, myeloma-spleen hybrids, and 
unfused parental cells. Only the myeloma-spleen hybrids are desired so a 
selection process must be introduced. The procedure used is a modifica­
tion of the hypoxanthine-aminopterin-thymidine selection described by 
Littlefield (96). 
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Myeloma cell lines used for fusion are resistant to 8-azaguanine and, 
hence, are defective in the enzyme hypoxanthine-guanine phosphoribosyl 
transferase (HPRT). HPRT negative myeloma cells cannot utilize exogenous 
hypoxanthine for purine synthesis, and they die when de novo synthesis of 
purines and pyrimidines is blocked by aminopterin. Spleen cells have a 
limited potential for growth in culture, and they die after about one week. 
Only hybrid cells which acquire a functional HRPT from a spleen cell and 
the potential to grow in culture from a myeloma cell can survive this 
selection procedure. 
Cell hybrids that survive the selection procedures are tested for 
specific antibody production after one to two weeks in culture, and gener­
ally only a small percentage of the hybrids produce antibody of interest. 
A wide variety of assay procedures has been described (48, 79) which are 
rapid, simple, and sensitive. Cultures that are identified as antibody 
producers are cloned to avoid overgrowth by nonproducing variants. Hybrids 
are retested for antibody production after cloning and positive cultures 
are frozen for preservation. Antibody may then be produced in culture, or 
the cells may be injected into mice where antibody producing tumors are 
formed. 
Once an antibody producing hybrid has been established, it can produce 
well-defined antibody indefinitely. Many times the monoclonal antibody can 
be used like conventional antiserum, but this is not always the case. 
Monoclonal antibodies have only a subset of the properties attributed to 
conventional antiserum. Many monoclonals do not precipitate antigen 
because they react with only one antigenic site and do not cross link 
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extensively. If a monoclonal antibody is not of the subclass that binds 
complement, then it will not be usable for direct cytotoxicity assays. 
Antibodies used for solid phase immunoassay have to be able to adhere to 
plastic and to bind antigen tightly. In general, the best way to obtain a 
monoclonal antibody with the desired properties is to do the initial 
screening using the type of assay for which the monoclonal antibody will 
be employed. 
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MATERIALS AND METHODS 
Antigen Preparation and Immunization 
Purified viruses used for antigen preparations were obtained from the 
laboratory of J. H. Hill (Dept. of Plant Pathology, Seed and Weed Sciences, 
Iowa State University). These purified virus preparations were produced 
from mechanically inoculated greenhouse plants using purification proce­
dures previously described (61, 64). Virus antigen was prepared for 
injection by mixing a solution containing 1 mg/ml of virus with an equal 
volume of Freund's complete adjuvant. A water in oil emulsion was produced 
by repeated passage of the mixture through an 18 gauge needle. Balb/C 
mice were injected in the intraperitoneal (i.p.) cavity with 100 yg of 
emulsified virus. One month or more after the primary injection, the mice 
were hyperimmunized by i.p. injection of 100 yg of virus in saline. Three 
to four days after hyperimmunization, the mice were bled via the retroorbi-
tal cavity or by cardiac puncture, and the immunological response was 
monitored using either a microprecipitin assay or an interfacial ring test. 
The microprecipitin assay described by van Slogteren (138) was 
performed by reacting dilutions of antiserum against the appropriate virus. 
The antiserum was diluted with borate buffered saline (BBS;0.05 M boric 
acid, 0.85% NaCl pH 7.2) and the virus which had a concentration of 1 mg/ml 
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^^ 260°nm ~ 2-4) was diluted in borate buffer (BB; 0.05 M boric acid pH 7.2). 
The results were recorded as the highest dilution of antiserum giving a 
precipitation reaction against 1 mg/ml of virus. Interfacial ring tests 
were performed as described by Ball (8). Samples of antiserum were 
20 
adjusted to contain a final concentration of 20% glycerol and placed into 
the bottom of small tubes. Samples containing 0.1 mg/ml of virus in BB 
were carefully placed on top of the dense antiserum to form a sharp inter­
face. The tubes were incubated at room temperature and observed for the 
formation of a precipitation ring near the interface. 
Growth of Myeloma Cells 
The mouse myeloma cells used in this work were the nonimmunoglobulin 
producing line Sp 2/0. This cell line as well as some advice on how to 
perform cell fusions were obtained from R. A. Van Deusen (National Veteri­
nary Services Laboratory, Ames, Iowa). Cells were grown in stationary 
suspension cultures at 37°C in a humidified atmosphere containing 5-7% CO^  
in air. Continuous cultures were maintained at a cell density of between 
5x10^  to 5x10^  cells/ml by diluting the cells 1:10 to 1:20 with growth 
medium every three to four days. Dulbecco's Modified Eagle's Medium (DMEM) 
was the growth medium used, and it consisted of 10 g of powdered DMEM 
(Gibco #430-1600), 3.5 g of glucose, 0.6 g L-glutamine, 6.0 g HEPES (25 mM), 
0.5 g sodium bicarbonate, and 100 ml of fetal bovine serum (10%) per liter. 
The medium was adjusted to pH 7.2, sterilized by filtration through a 
0.22 ym membrane filter, and stored at -20°C. 
Exponentially growing myeloma cells were required for optimum results 
during cell fusions. These were obtained by diluting a rapidly growing 
culture 1:2 with growth medium every day for a period of three to four days 
before the cell fusion. At bimonthly intervals, the Sp 2/0 cells were 
passed twice through DMEM containing 20 yg/ml of 8-azaguanine to insure the 
maintenance of the HPRT defect and subsequent sensitivity to aminopterin. 
21 
Preparation of Spleen Cell Suspensions 
Three to four days after hyperiiranunization, mice that demonstrated a 
positive immunological response were killed either by exsanguination or 
cervical dislocation. The body was thoroughly washed with 70% ethanol, and 
the spleen was aseptically removed and placed into a petri dish containing 
5 ml of DMEM and a Cellector tissue sieve (Bellco Glass, Vineland, N.J.)-
The spleen was perfused with DMEM to loosen the cells and then gently 
rubbed across the 80 mesh stainless steel screen in the Cellector to break 
the cells into a single cell suspension. The spleen cell preparation was 
checked for viable cell number by diluting one part cell suspension with 
one part of the viability stain of Parks et al. (111). This stain 
consisted of 1 ppm acridine orange and 1 ppm ethidium bromide in 0.85% 
sodium chloride. When preparations were viewed with a fluorescence micro­
scope, live cells were stained green and dead cells orange. Spleens 
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generally produced about 10 cells with a viability of greater than 95%. 
Somatic Cell Hybridization 
The cell fusion procedure used was a slight modification of previously 
described protocols (47, 137). The spleen cell suspension was added to 
exponentially growing SP 2/0 cells in a 1:1 ratio, and the mixed cells were 
pelleted at 250 xg (g max.) for 10 minutes. The growth medium was removed 
and saved for conditioned medium (CM = DMEM that SP 2/0 cells have grown in 
for three to four days). Cells were gently loosened from the pellet, and 
1.0 ml of 45% polyethylene glycol 1540 (PEG; American Type Culture Collec­
tion, Rockville, MD.) in serum free DMEM was slowly added over a period of 
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30 sec. The cells were incubated in the PEG solution at room temperature 
for 2 min. with gentle agitation. The PEG solution was diluted with 1.0 ml 
of DMEM added over a 30 sec. period, and the cells were incubated for 
another 2 min. Ten ml of DMEM were added over a 1 minute period with gentle 
agitation, and the cell suspension was incubated for 5 min. Cells were 
pelleted at 250 xg for 10 min. The supernatant was discarded, and the 
pellet was resuspended in medium consisting of one part DMEM and one part 
CM (DMEM-CM) to a density of 2.5x10^  myeloma cells/ml. An appropriate 
volume (1:100 dilution in DMEM-CM) of lOOX hypoxanthine-aminoptërin-
thymidine (lOOX HAT, Dutchland Laboratories, Denver, PA.) was added to 
apply selective pressure, and the cell suspension was plated at 0.2 ml/well 
in a 96 well tissue culture plate using a wide mouth pipette. 
Growth of Hybrid Cells 
Plates containing hybrids were incubated in a 37°C humidified CO^  
incubator and observed for medium color changes indicating cell metabolism. 
When the medium had turned a yellow-orange color (three to four days), the 
cells were fed by removing 0.1 ml from each well and replacing it with 
DMEM. About one week after fusion, the plate was examined for the presence 
of growing hybrids which can be distinguished from the background of dead 
cells. Medium added after the first week was used to wean the cells off of 
aminopterin, and it contained hypoxanthine and thymidine (lOOX HT, Dutch-
land Laboratories). Hybrids were tested for the production of specific 
antibody when the cells had grown enough to cover one-fourth of the well. 
Antibody testing was performed two to three days after medium was added to 
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the wells. Hybrids that produced antibody were transferred to two wells of 
a new 96 well tissue culture plate and after about one week were trans-
2 ferred to a 25 cm tissue culture flask. The tissue culture flask was 
Incubated in the upright position for the first week, and the hybrids were 
fed with DMEM. 
Indirect ELISA Assay 
Assays used for the screening of monoclonal antibody production have 
to be rapid because a lot of samples are processed and sensitive because 
very little antibody is present in the small 96 well tissue culture plates. 
The indirect ELISA was chosen because it is very sensitive and easily 
adaptable to the 96 well format using microtiter plates. The procedures 
and buffers used were essentially as outlined by Voiler et al. (141). 
Virus antigen (10 pg/ml, 100 yl/well) was immobilized to polystyrene micro­
titer plates in 0.05 M carbonate-bicarbonate coating buffer at pH 9.6 for 
1 hr. at 37°C. The virus solution was removed, and unbound protein binding 
sites were blocked using 300 yl of 0.01 M phosphate buffered saline-pH 7.4 
containing 1% bovine serum albumin (PBS-BSA or blocking solution) for 
15 min. at 37°C. Blocking solution was removed, and the plates were 
rinsed once with 0.01 M PBS containing 0.05% Tween 20 (wash). Fifty to 
100 yl of the test sample was added and incubated for 1 hr. at 37°C. The 
plates were washed twice, and 50 yl of alkaline phosphatase labeled rabbit 
immunoglobulin, specific for mouse IgG (Sigma #A1902 diluted 1:1500 in 
PBS-BSA), was added. Plates were incubated for 1 hr. at 37°C, washed four 
times, and 50 yl of substrate solution was added (10% diethanolamine 
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pH 9.8 containing 1 mg/ml p-nitrophenyl phosphate). Positive samples 
turned yellow usually within 15 min. whereas negative samples and controls 
remained colorless for at least 1 hr. Results were generally determined 
visually; however, they could be quantitated by stopping the reaction after 
30 min. with 50 yl of 3N sodium hydroxide and measuring the reaction 
products spectrophotometricly at 405 nm. 
A modification of the indirect ELISA was used to determine the IgG 
subclass of the monoclonal antibodies. This procedure used a subclass 
specific rabbit antimouse immunoglobulin (Zymed Laboratories, Burlingame, 
CA.) which bound to the monoclonal antibody, followed by peroxidase labeled 
goat antirabbit immunoglobulin (Zymed). The substrate solution contained 
1 mM 2,2'-azino-di-3-ethylbenzthlozoline sulfuric acid (ABTS) in 0.1 M 
citrate buffer pH 4.0 with 1 pl/ml of 30% HgOg. The blue-green reaction 
products were visually monitored. 
Cell Cloning 
Hybrids that produce specific antibody may be cloned using semisolid 
agar (48, 137) or limiting dilution (48) cloning techniques. Agar cloning 
4 involves seeding about 10 cells in 4 ml of medium containing DMEM-CM with 
0.25% agar. After 7-10 days, visible clones are picked and seeded into 
96 well tissue culture plates. Limiting dilution cloning involves diluting 
hybrid cells with DMEM-CM such that only one cell is present in a micro-
culture well. After about one week, the cultures are examined microscopi­
cally, and a culture well containing only one cell cluster is expanded. 
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Cell Freezing 
Hybrid cells were frozen for long-term storage to insure that reserve 
cell stocks were available in case the continuously growing cultures lost 
antibody production or became contaminated. Actively growing cells were 
pelleted at 250 xg for 10 min., resuspended to a density of 1-2x10^ cells/ 
ml in serum containing 10% dimethylsulfoxide, and placed in plastic cryo­
genic vials (Nunc; Vangard International, Neptune, NJ.). The vials were 
placed inside freezing chambers that had 1 inch thick styrofoam walls, and 
these were placed directly into a -70°C freezer. Leaving the cells at 
-70°C would maintain viability for six months to one year; longer storage 
times required placing the frozen vials in liquid nitrogen. 
Antibody Production 
Tissue culture fluid contained too low a concentration of antibody for 
easy, rapid purification of milligram amounts of antibody. Therefore, the 
monoclonal antibodies used in radioimmunoassays were produced in mice. 
Mice were primed with 0.5 ml of pristane i.p. one week to one month before 
injection of the monoclonal antibody producing cells. Cells were pelleted 
from actively growing cultures by centrifugation at 250 xg for 10 min. and 
resuspended in DMEM at 5x10^ cells/ml. The mice were injected i.p. with 
0.1 to 0.2 ml of the cell suspension. One to two weeks after injection, 
the mice were examined for external signs of tumor development. When the 
abdomen was distended, the ascitic fluid was collected by puncturing the 
abdominal wall with an 18 gauge needle. Ascitic fluid was processed by 
centrifugation at 1000 xg to remove cells, and the antibody containing 
supernatant was stored at -20®C. 
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Antibody Purification 
Antibody was purified from ascitic fluid initially by precipitation 
with ammonium sulfate at a final concentration of one-third saturation 
(19). This method, however, produced a product with considerable contami­
nation. To obtain a purer antibody preparation, protein A affinity chroma­
tography was performed (42, 143). Protein A-Sepharose CL-4B (Pharmacia, 
Piscataway, NJ.) was rehydrated in 0.1 M NagHPO^ pH 8.0 for 30 min. and 
packed into a small column (1 cm x 15 cm, containing 5 ml of gel). One ml 
of 0.5 M Na^HPO^ pH 8,0 was added to 4 ml of ascitic fluid, and the mixture 
was clarified by centrifugation at 1000 xg. The supernatant was applied to 
the protein A column and washed with 0.1 M NagHPO^ pH 8.0 until the Aggg of 
the effluent was below 0.05. IgG was eluted from the column using 0.5% 
acetic acid in 0.85% NaCl pH 3.0. The eluting immunoglobulin was monitored 
spectrophotometrically, and the A„__ peak was collected. Samples were 
ZoU 
adjusted to pH 7.0-8.0 with IN NaOH and stored at -20°C. 
Purification of the antibody preparations was monitored using indirect 
ELISA ar sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-
PAGE). SDS-PAGE was performed using 4 to 12% linear gradient gels as 
described by Takacs (133). The system used was Laemli's tris-glycine 
discontinuous buffer (89) with a 29:1 acrylamide to methylene-bis-acrylamide 
ratio. Proteins were visualized by staining with 0.1% coomassie brilliant 
blue. 
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Tritium Labeling 
Protein A purified monoclonal antibodies were tritium labeled using 
the sodium borohydride exchange reaction described by Rifkin et al. (120). 
The antibody solution was adjusted to contain 0.05 M HEPES at pH 7.5 and 
clarified by centrifugation at 1000 xg for 10 min. Pyridoxal-5'-phosphate 
(PLP; A grade, Calbiochem, La Jolla, CA.) at a concentration of 0.01 M in 
the HEPES buffer was added to the antibody solution at a ratio of 5 yl PLP 
per mg of antibody and incubated for 30 min. at 37°C. The mixture was 
cooled in an ice bath and added sequentially to vials containing 25 mCi of 
tritiated sodium borohydride (Research Products International Corp., Elk 
Grove Village, IL., specific activity 10-20 Ci/mM) . The mixture was incu­
bated for 5 min. in an ice bath with each 25 mCi vial (2 vials/mg of 
antibody) and for 15 min. with the final vial. Excess 0.1 M PLP was added 
to inactivate residual sodium borohydride, and the density of the mixture 
was increased by adding glycerol to 10% final concentration. Protein 
bound tritium was separated from unbound tritium by gel filtration 
chromatography on a Sephadex G-25 (Pharmacia, Piscataway, NJ.) column using 
BBS as the elutant. The AggQ peak was collected, and the protein concen-
0.17 tration was determined (Eggg* = 1.4). A 0.1 ml sample of the tritiated 
antibody was added to 0.9 ml of BBS containing 0.1% BSA, and 0.2 ml of this 
mixture was used to determine the total cpm/ml. The remaining 0.8 ml of 
tritiated antibody solution was precipitated with 2.4 ml of cold 10% 
trichloroacetic acid. After 30 min. at 4°C, the precipitate was pelleted 
by centrifugation, and 0.2 ml of the supernatant was used to determine the 
fraction of tritium bound to the antibody. Radioactivity was determined by 
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placing the 0.2 ml samples into 5 ml of Riafluor (New England Nuclear, 
Boston, MA.), after which the samples were counted in a liquid scintilla­
tion counter. The specific activity (SA) of the tritiated antibody was 
determined from its protein concentration and radioactive content using the 
formula SA = (T/C)(P) in which T equals the total cpm/ml, C equals the 
protein concentration in mg/ml, and P equals the fraction of tritium (as 
measured in cpm) bound to the protein. 
Double Antibody Sandwich RIA 
The procedure used for the double antibody RIA was essentially as 
described by Bryant et al. (17). Virus specific antibody was adsorbed to 
3.4 mm polystyrene beads (Precision Plastic Ball Co., Chicago, XL.) by end-
over-end mixing, overnight at room temperature, in a solution containing 
10 yg of antibody/bead in 0.05 M carbonate buffer pH 9.6 (5 ml/50 beads). 
The beads were blocked using PBS-BSA for 1 hr. at room temperature with 
end-over-end mixing and washed once in PBS. The coated beads could be used 
immediately or stored (for up to one month) at 4°C. The antibody coated 
beads were dispensed individually into plastic tubes that had been blocked 
with PBS-BSA for 1 hr. at room temperature. Samples diluted in BB 
containing 0.5% sodium hexametaphosphate (BB-HMP) were added to the tubes 
and incubated overnight with gentle agitation. Sample solution was aspi­
rated; the beads were washed three times and transferred to new blocked 
tubes. 
Two hundred yl of tritium labeled antibody in PBS-BSA, at a predeter­
mined optimum concentration, were added to each bead and incubated for 
4 hr. at room temperature with gentle agitation. The labeled antibody was 
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aspirated; the beads were washed three times and transferred to 5 ml of 
Riafluor for liquid scintillation counting. The number of counts was 
directly proportional to the amount of virus present in the sample. The 
optimum concentration of tritiated antibody was determined by incubating 
antibody coated beads in samples containing either 1000 ng of virus for 
specific binding or no virus for nonspecific binding. These beads were 
then reacted with various concentrations of labeled antibody, and the 
radioactivity bound was counted. The concentration of tritiated antibody 
at which the ratio of specifically bound to nonspecifically bound counts 
was maximized was used as the optimum (63)• 
Inhibition RIA 
In the inhibition RIA, the solid phase polystyrene beads were coated 
with virus antigen at a concentration of 1-10 pg/bead in carbonate buffer 
and blocked with PBS-BSA as described for the double antibody RIA. Samples 
were diluted in BB-HMP and added to blocked plastic tubes containing 
tritiated antibody in PBS-BSA. The mixture was incubated at room tempera­
ture with agitation. After 1 hr., an antigen coated bead was added to each 
tube, and incubation was continued for another hour. The solution was 
aspirated, and the bead was washed three times with PBS. The polystyrene 
bead was placed into 5 ml of Riafluor, and the radioactivity was counted. 
The number of counts was inversely proportional to the amount of virus 
present in the sample. 
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RESULTS 
Monoclonal Antibody Development 
Prior to the initial cell fusion attempts, the various components 
involved in a fusion were investigated on an individual basis. Myeloma 
cells maintained good growth rate and demonstrated the expected resistance 
to 8-azaguanine and sensitivity to aminopterin. Response of Balb/C mice 
to immunization with virus was measured using a microprecipitin assay in 
order to quantitate antibody production or with an interfacial ring test to 
confirm the presence of antibody. Microprecipitin assays of mouse anti­
serum reacted against 1 mg/ml of virus had a titer of 1:256 which demon­
strated that the mice responded fairly well to virus antigen. Interfacial 
ring tests were performed the day before cell fusion to confirm that the 
mouse was producing virus specific antibody. The amount of precipitate 
formed at the interface could also be used to estimate the quantity of 
antibody present. Removal of spleens and the preparation of single cell 
suspensions were monitored by using acridine orange-ethidium bromide 
viability staining, and the results indicated a 95% viability for the 
spleen cell preparations. 
The first series of cell fusions performed did not produce any 
hybrids; therefore, the procedures and reagents used were investigated more 
intensively. Among the parameters investigated were changes in the 
myeloma to spleen cell ratio, methods of spleen cell preparation, changes 
in cell fusion times and reagents, changes in growth medium composition, 
and changes in serum lots and concentration. A considerable amount of time 
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was involved optimizing parameters before fusions began to produce success­
ful hybrid cells. Changes of the serum lots apparently were primarily 
responsible for eventual success. When conditions were optimized, cell 
fusions would produce hybrids in 70 to 80% of the tissue culture wells. 
Hybrids could be differentiated from other cells by their size and light 
refraction and would be noticeable by four to seven days after the fusion. 
Hybrids were tested for virus specific antibody by indirect ELISA 
10-14 days after fusion and about 10-20% of the hybrids would produce anti­
body of interest. During the process of expanding hybrids of interest for 
cloning and freezing, there was a significant problem with instability. 
Some of the hybrids after growing for two to three weeks lost the ability 
for growth in culture, whereas other hybrids lost the ability to produce 
virus specific antibody. Hybrids that were growing well and still produced 
virus specific antibody about one month after the fusion generally remained 
stable. The hybrids used for ascities fluid production and the development 
of immunoassays have been repeatedly frozen and recovered and have remained 
stable for eight to ten months. 
These hybrid cell lines along with the specificities and characteris­
tics of the antibody they secrete are summarized in Table 1. 
Double Antibody Sandwich RIA 
The use of these monoclonal antibodies in immunoassay was first inves­
tigated using MAI antibody. Ascitic fluid was processed by centrifugation 
and ammonium sulfate precipitation. Protein was tritium labeled using the 
sodium borohydride exchange reaction and a specific activity of about 
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Table 1. Monoclonal antibodies to SMV, LMV, MDMV-A, and MDMV-B 
Hybrid IgG subclass Virus specificity ELISA titer^ 
51 IgG2aK SMV 1:10^ 
52 IgG2aK SMV 1:10^ „ 
L5 IgG2bK LMV (SMV, MDMV-A&B) 1:10^(1:10 ) 
MAI IgG3K MDMV-A 1:10% 
MB3 IgG3K MDMV-B 1:10% 
MB4 IgG2bK MDMV-B 1:10, 
MB6 IgG3K MDMV-B 1:10^ 
MB8 IgG2aK MDMV-B 1:10 
^The ELISA titer was determined on serial dilutions of clarified 
ascitic fluid in an indirect ELISA using 5 yg/ml of virus antigen. All of 
the antibodies were tested against tobacco mosaic virus and cowpea mosaic 
virus, and no cross reaction was observed. The L5. antibody demonstrated a 
low level of cross reaction with SMV, MDMV-A, and MDMV-B. The SI and S2 
antibodies were tested against SMV strains Gl, G2, 03, G4, G5, and 75-16-1 
and demonstrated reactivity with all strains. 
16 yCi per mg of protein was obtained. Labeling did not affect immunologi­
cal activity as measured by the indirect ELISA. Tritium labeled antibody 
was used in a double antibody sandwich RIA for the detection of MDMV-A 
antigen. 
The quantity of tritium labeled antibody used had to be optimized, and 
those results are presented in Figure 1. The number of counts bound in the 
presence of antigen (P) was divided by the counts bound nonspecifically in 
the absence of antigen (N) to determine the P to N ratio. P to N ratio 
curves have a peak representing the concentration of tritiated immuno­
globulin at which sensitivity of the RIA system will be optimized. The MAI 
double antibody RIA had an optimum at 0.5 yg of tritiated antibody so this 
Figure 1. Determination of the optimum tritiated antibody concentration 
for the MDMV-A double antibody RIA. Beads were coated overnight 
with (10 yg/bead) MAI in carbonate buffer and reacted with 
either 1000 or 0 ng of MDMV-A. Tritiated antibody (MAI) was 
added at various concentrations, and the binding activities in 
the presence (P) and absence (N) of virus were measured. The 
ratio of activities (P/N) was calculated and plotted 
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level was used for quantifying response to viral antigen. A serial dilu­
tion curve of MDMV-A was examined in the RIA system, and there was a slight 
response to viral antigen at the higher virus concentrations (Figure 2); 
however, the assay lacked sensitivity. 
Investigations were started to determine why the assay lacked accept­
able sensitivity. Processed antibody was analyzed on polyacrylamide gels 
to determine the amount of contaminating protein present. Stained gels 
revealed a large number of protein bands, and it was decided to try further 
purification of the antibody. Ascitic fluid was placed on a protein A-
Sepharose affinity chromatography column, and the bound IgG was eluted by 
changing the pH. Fractions were collected and the absorbance at 280 nm was 
measured to monitor the eluting protein. The elution profile shown in 
Figure 3 demonstrated a good separation of contaminating proteins, present 
in fractions 2-6, from IgG released in fractions 11-13. Electrophoresis 
was performed on samples from both peaks. The first peak had a protein 
pattern similar to ascitic fluid, and the second peak contained only two 
protein bands representing the heavy and light chains of IgG. 
During protein A-Sepharose purification, it was noticed that the maxi­
mum binding capacity of the column was different for the various monoclonal 
antibodies purified. These differences in antibody binding were measured 
by determining the amount of antibody that would bind to 0.5 ml protein A 
columns. The results (Table 2) indicated that even antibodies of the same 
IgG subclass varied by more than twofold in their ability to bind to 
protein A. 
Figure 2. Relationship between concentration of viral antigen and the 
number of counts bound for the MDMV-A double antibody RIA. 
Beads were coated with MAI (10 yg/bead), reacted with various 
concentrations of virus and then 1 pg of tritiated MAI was added. 
This graph is representative of three sets of experimental data 
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Figure 3. Protein A purification of ascitic fluid. The large peak repre­
sents contaminating protein washed through the column at pH 8.0. 
The pH was changed to 3.0 as indicated by the arrow, and the 
smaller antibody peak was collected 
39 
13 
12 
11 
10 
9 
8 
7 
280 
6 
5 
4 
3 
2 
1 
7 3 9 10 11 12 13 14 15 1 2 4 5 6 8 
Fraction Number 
40 
Table 2. Binding of monoclonal antibodies to protein A 
Mg bound to 0.5 ml 
Monoclonal antibody protein A-Sepharose 
SI IgG2a 1.1 
S2 IgG2a 2.5 
L5 IgG2b 1.7 
MAI IgG3 2.1 
Protein A purified antibodies were used for further work on develop­
ment of immunoassays. The SI monoclonal antibody was tritium labeled to a 
specific activity of 15 liCi/mg and compared, in a double antibody RIA, to a 
previously developed system based on rabbit polyclonal antibody (RP). 
Optimum concentration for the tritiated IgG was about 1 yg for both systems 
(Figure 4) as determined by the P to N ratio. When a dilution curve of 
viral antigen was prepared and used to compare the two systems (Figure 5), 
the RP system had a much better response than the SI system to viral 
antigen. 
To help determine why 81 had very poor activity, the various steps in 
the double antibody RIA were investigated separately. A direct RIA was 
designed to determine how well-tritiated SI would bind to polystyrene 
immobilized SMV. The results of that experiment (Figure 6) indicated that 
tritiated SI bound to SMV better than the tritiated RP. Further experi­
ments used a mixed double antibody RIA in which SI was used as capture (or 
coating) antibody or tritiated RP, and RP was used as capture antibody for 
Figure 4. Determination of the optimum tritiated antibody concentrations 
for the SMV double antibody RIA (as described in Figure 1). 
RP-RP represents rabbit coating antibody used with rabbit tri­
tiated antibody. Sl-Sl represents SI coating antibody used with 
SI tritiated antibody 
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Figure 5. Relationship between concentration of viral antigen and the 
number of counts bound for the SMV double antibody RIA. RP-RP 
represents rabbit coating antibody used with rabbit tritiated 
antibody (1 yg/bead). Sl-Sl represents SI coating antibody and 
SI tritiated antibody (1 yg/bead) . This graph is representa­
tive of four sets of experimental data 
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Figure 6. Binding of tritiated SI and tritiated rabbit antibody (RP) to 
polystyrene immobilized SMV. SMV was bound to beads overnight 
in carbonate buffer. One yg of tritiated antibody was added to 
the beads and incubated for 1 hr. This graph is representative 
of two sets of experimental data 
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tritlated SI. A tritiated antibody concentration of 1 yg was chosen based 
on the P to N ratio shown in Figure 7. Figure 8 shows the response of the 
mixed antibody RIA to a standard curve of SMV. These data indicate that the 
SI antibody works well as a capture antibody for tritiated RP, but when RP 
antibody is used as capture for tritiated SI, the assay lacked acceptable 
sensitivity. 
The results to this point had demonstrated that 81 antibody would work 
as capture antibody and that tritiated SI would bind to immobilized SMV. 
Perhaps the double antibody system did not work because a limited number of 
antigenic sites for the SI antibody existed on SMV. This possibility was 
investigated by using two other monoclonal antibodies that reacted with 
SMV. An experiment was performed in which the antibodies S2, L5, and SI 
were used as capture antibody for tritiated SI. The results presented in 
Figure 9 showed that SI and L5 did not work well as capture antibody for 
tritiated SI. The S2 capture antibody, however, when combined with 
tritiated SI gave an RIA with good response to viral antigen and a sensi­
tivity down to about 25 ng of SMV. Apparently the S2 antibody binds to a 
different antigenic site on SMV and doesn't block the binding of triti­
ated SI. This was confirmed by performing a competition direct RIA in 
which it was demonstrated that unlabeled S2 did not block the binding of 
tritiated SI while unlabeled SI reduced the binding of tritiated SI five­
fold. 
Figure 7. Determination of optimum concentrations of tritiated antibody 
for the SMV mixed double antibody RIA as described in Figure 1. 
Sl-RP represents SI coating antibody used with tritiated rabbit 
antibody. RP-Sl represents rabbit coating antibody used with 
tritiated SI antibody 
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Figure 8. Relationship between concentration of viral antigen and the 
number of counts bound for the SMV mixed double antibody RIA. 
Sl-RP represents SI coating antibody used with tritiated rabbit 
antibody. RP-Sl represents rabbit coating antibody used with 
tritiated SI antibody. The specific activity of RP was 13.2 
yCi/mg and the specific activity of SI was 14.7 yCi/mg. This 
graph is representative of three sets of experimental data 
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Figure 9. Relationship between the concentration of viral antigen and the 
number of counts bound for the SMV double antibody RIA using SI, 
S2, or L5 as a coating antibody for tritiated SI (1 yg). This 
graph is representative of three sets of experimental data 
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Inhibition RIA 
Protein A purified MAI and L5 antibodies were tritium labeled and 
investigated for use in immunoassays. The specific activity of MAI was 
about 13 pCi/mg whereas the specific activity for L5 was about 3 yCi/mg. 
Both of these antibodies were first examined in a double antibody RIA. The 
sensitivity was unacceptable presumably due to the limited antigenic sites 
available on MDMV-A and LMV. It was decided to try modifying a direct RIA, 
in which tritiated antibody binds to immobilized virus, into an inhibition 
RIA in which sample virus would Inhibit the binding of tritiated antibody 
to polysytrene immobilized virus. Optimization of this type of assay 
required Investigation of immobilized virus and tritiated antibody concen­
trations in the presence or absence of sample virus. 
Detection of MDMV-A with MAI antibody was the first system developed 
for inhibition RIA, and the results are presented in Figure 10. The assay 
had a sensitivity of 10 ng of virus and a very good response to viral 
antigen. An inhibition RIA developed with L5 for LMV (Figure 11) and with 
MB4 for MDMV-B (not shown) had very similar results. An inhibition RIA was 
also developed for SMV using the SI antibody (Figure 12), and a sensitivity 
of 50 ng was obtained. The SMV inhibition RIA was tested in the presence 
and absence of ground soybean seed to determine if the assay had the poten­
tial to detect virus infected seed. Figure 13 shows that the presence of 
ground seed does affect the assay causing a decrease in the total number of 
counts bound. Responsiveness to viral antigen is reduced somewhat; 
however, the assay remained sensitive to the 50 ng level. 
Figure 10. Relationship between the concentration of viral antigen and the 
number of counts bound for the MDMV-A inhibition assay. One yg 
of MDMV-A was bound to the beads, and 1 pg of tritiated MAI was 
used in the assay. This graph is representative of four sets 
of experimental data 
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Figure 11. Relationship between the concentration of viral antigen and the 
number of counts bound for the LMV inhibition assay. Ten yg of 
LMV were bound to the beads, and 2 yg of tritiated L5 were used 
in the assay. This graph is representative of two sets of 
experimental data 
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Figure 12. Relationship between the concentration of viral antigen and the 
number of counts bound for the SMV Inhibition assay. One i_ig of 
SMV was bound to the beads, and 1 yg of tritiated SI was used 
in the assay. This graph is representative of three sets of 
experimental data 
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Figure 13. Relationship between the concentration of viral antigen and the 
number of counts bound for the SMV inhibition assay in the 
presence of ground soybean seed. Virus was added to batches of 
100 seeds, and the seeds were ground in BB with a Brinkman 
Polytron homogenizer at a setting of six. This graph is repre­
sentative of two sets of experimental data 
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Some of the monoclonal antibodies were also examined for use as immu-
nopurification reagents. Attempts to bind MAI antibody onto Affi-Gel 10 
and Sepharose 4B (using the manufacturer's guidelines) while maintaining 
immunological activity were unsuccessful. Attaching the antibody to 
Protein A-Sepharose, however, resulted in columns capable of removing virus 
particles from solution as shown in Table 3. The virus particles were 
eluted from the protein A column along with the attached antibody when the 
buffer was changed to pH 3.0; however, the virus particles were not infec­
tive when inoculated onto susceptible host plants. 
Table 3. Binding of MDMV-A by Protein A immobilized antibody 
Antibody bound to Percent of the A2gQ removed 
Protein A-Sepharose from a MDMV-A solution^ 
S2 0 
MAI 70 
^Two mg of antibody were bound to 0.5 ml columns of Protein A-
Sepharose. 
^About 0.7 mg of purified MDMV-A was added to each column, unbound 
virus was washed off, and the reduction of A absorbing material was 
measured. 
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DISCUSSION 
Problems encountered with the production of hybrid cells appeared to be 
primarily related to serum growth factors. Manipulation of other factors 
involved in the fusion process did not produce successful results. Serum 
was tested by monitoring the growth of myeloma cells after plating at low 
cell density, a commonly used technique in hydridoma work. All of the 
serum lots tested supported the growth of myeloma cells and stable hybrids; 
however, only one lot of serum supported hybrid development, and that serum 
lot was used for all subsequent cell fusions. Apparently just after fusion 
the cells were more fastidious, requiring components that were deficient in 
most of the serum lots tested. 
Hybrid instability is another commonly encountered problem in hybridoma 
work. This is caused by the unstable chromosome number of fused cells. 
During fusion, the chromosome number is increased due to the combining of 
parental chromosomes; the chromosome number then decreases as the hybrid 
cell grows and divides. Expulsion of chromosomes occurs obstensibly in a 
random manner producing, after about one month, a stable hybrid cell whose 
chromosome number is generally somewhat higher than that of either parent. 
If a hybrid loses chromosomes that are necessary for growth in culture 
or antibody production, then the hybrid is of no use for monoclonal antibody 
production. Some hybrids maintain antibody production and the ability to 
grow in culture but lose the ability to produce ascities tumors in mice. 
These can be used for monoclonal antibody production, but only lower titer 
culture fluids can be obtained. Even after a prolonged time period, stable 
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hybrids that are continuously maintained in culture can lose antibody 
production due to chromosome loss or somatic cell mutations. Therefore, it 
is important to maintain frozen stocks of antibody producing cells. 
Monoclonal antibodies produced in this project were all of the IgG2a, 
IgG2b, or IgG3 subclasses. This was somewhat unexpected because the IgGl 
subclass is the most prevalent in mouse antiserum. It has been shown that 
thymus-dependent antigens elicit predominantly IgGl antibody (113, 130, 
143). Thymus-independent antigens on the other hand elicit mainly IgG3 
and IgG2 (113, 130, 143). The fact that all the monoclonal antibodies were 
IgG3 or IgG2 suggests that the viral antigens were acting as thymus-
independent antigens. Antibody light chains were all of the kappa class 
which was expected because kappa light chains predominate in mouse IgG. 
Most of the monoclonal antibodies were specific only for the virus 
they were developed against and did not crossreact with other potyvirus 
members. However, the L5 monoclonal antibody, produced in either ascitic 
fluid or culture fluid, did crossreact with SMV, MDMV-A, and MDMV-B. 
ELISA titers of L5 were considerably lower with SMV, MDMV-A, and MDMV-B 
than with LMV, indicating that the other three viruses have an antigenic 
site similar but not identical to the antigenic site on LMV. The SMV 
specific monoclonal antibodies SI and 82 were tested against various 
strains of SMV, and no strain specific differences were detected. This 
indicates that the SI and S2 antigenic sites are present on all the SMV 
strains tested. 
Radiolabeling of antibody for use in R.I.A. was monitored to determine 
its effect on antibody activity and to measure the specific activity 
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obtained. Antibody activity as measured by the indirect ELISA was not 
affected confirming the reports (31) that the labeling procedure was very 
gentle. The specific activities obtained were in the range of 15 yCi/mg 
for rabbit antibody, SI and MAI; however, L5 had a lower specific activity 
of 3 pCi/mg. 
The use of the monoclonal antibodies for immunoassay was first inves­
tigated using a double antibody RIA. A double antibody system was chosen 
because that type of assay had been developed in this laboratory, using 
rabbit polyclonal antibody (RP), for the detection of SMV. Most of the 
parameters that had been optimized for the rabbit antibody were applicable 
to monoclonal antibodies. A direct comparison could also be made between 
rabbit antibody and monoclonal antibody for the detection of SMV. 
Development of an immunoassay for the detection of MDMV-A using MA-1 
antibody was attempted because it was the first monoclonal for which high 
titer ascitic fluid was available. Optimization of the MA-1 antibody 
concentrations gave results similar to those obtained with the rabbit anti-
SMV system (Figure 1). The ratio of counts bound in the presence and 
absence of virus (P to N ratio) reached a maximum at a tritiated antibody 
level of about 1 yg for both systems. However, the maximum F to N ratio 
was significantly lower with tritiated MA-1. This lower P to N ratio 
suggested a poor sensitivity to viral antigen, and this was confirmed when 
a standard curve was constructed (Figure 2). The number of counts bound 
was considerably lower than that achieved with the rabbit anti-SMV system. 
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Polyacrylamide gel electrophoresis of the MAI antibody preparation 
revealed a large number of contaminating proteins while the affinity puri­
fied rabbit antibody contained only two main polypeptides, corresponding to 
the heavy and light chains of IgG. Contaminating protein would compete 
with antibody during the tritium labeling resulting in a reduction of the 
tritium binding to antibody. This probably was the reason for the poor 
sensitivity of the MAI assay so further purification was attempted. 
Protein A purification was very successful (Figure 3), producing an anti­
body fraction that contained only two polypeptides when analyzed by SDS-
PAGE. 
When the various monoclonal antibodies were measured for the ability 
to bind to protein A, significant differences were noted. It had previ­
ously been shown (42, 143) that different IgG subclasses bind to protein A 
with different affinities. In this study, however, antibodies of the same 
IgG subclass (SI and 82) demonstrated more than a twofold difference in the 
ability to bind to protein A (Table 2). These differences are probably due 
to variations of the amino acid sequence in the Fc region responsible for 
binding to protein A. These data point out the individual nature inherent 
in monoclonal antibodies. Each monoclonal antibody has its own character­
istics which do not always conform to those that have been observed in 
studies on polyclonal antibodies. Because of this, some of the classical 
immunological methods for purification, conjugation, labeling, and storage 
do not work with all monoclonal antibodies. For example, in this research, 
problems were encountered with storage of the S2 antibody. S2 lost activ­
ity after two weeks at 4°C while the other monoclonal antibodies and rabbit 
antibody remained active for months. 
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Protein A purified SI antibody was chosen for further work with the 
double antibody RIA because it had the highest titer, and the assay could 
be compared to the rabbit anti-SMV assay. Comparing the P to N ratios for 
the SI and RP systems (Figure 4), it was observed that the optimums were 
about the same. The peak, however, was much higher with the RP system, and 
a standard curve (Figure 5) demonstrated a much better response for the RP 
system. Even though SI antibody was active in binding to SMV as shown by 
indirect ELISA, it was not performing as expected in the double antibody 
RIA. It was decided to directly compare the SMV binding activity of 
tritiated SI and RP. These results (Figure 6) were somewhat surprising 
because they were the opposite of those obtained in the double antibody 
RIA. SI antibody demonstrated much better response than the RP antibody to 
viral antigen. 
It was not clear why RP had such a low response to immobilized SMV; 
perhaps binding the antigen to polystyrene at pH 9.6 changed the antigenic 
sites and reduced the binding activity of RP. The results obtained with SI 
suggested that the problem encountered with the double antibody system had 
to do with using SI as a capture antibody or the binding of SI to native 
virus. 
To test the ability of SI to act as a capture antibody and to further 
investigate the activity of tritiated SI with native virus, a mixed double 
antibody RIA combining both RP and SI was used. The mixed double antibody 
RIA demonstrated (Figure 8) that SI could act as a capture antibody for 
tritiated RP; however, when RP was used as a capture antibody for tritiated 
SI, the results were low sensitivity for viral antigen. It was now 
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established that SI would adsorb to polystyrene and could bind to native or 
immobilized SMV; however, for some reason it was not active in a double 
antibody R.I.A. 
All of these results pointed to a problem with a limited number of 
antigenic sites on SMV for the SI antibody. This problem was unexpected 
because each SMV particle contains multiple copies of the capsid protein 
and, therefore, multiple copies of the antigenic sites. However, a limited 
number of antigenic sites was the only explanation consistent with the 
results obtained. 
One way to circumvent this problem would be to use another monoclonal 
antibody with an affinity for a different antigenic site on SMV as capture 
antibody. There were two other monoclonal antibodies available that bound 
to SMV, S2 which bound only to SMV and L5 which bound to both LMV and SMV. 
L5 probably binds to a different antigenic site than SI because of its 
different virus specificity, but the affinity of S2 was not known. 
The L5-S1 assay demonstrated almost no response to viral antigen which 
was surprising. Possibly the titer of L5 for SMV was too low to be effec­
tive. On the other hand, the S2-S1 assay had a very good response to viral 
antigen with a sensitivity down to 50 ng of SMV. These results strongly 
indicate that S2 binds to a different antigenic site than SI on SMV and 
that the problems encountered with using only SI in a double antibody assay 
were due to limited antigenic sites. When two monoclonal antibodies with 
different affinities were used, however, the double antibody technique 
worked. Further experiments, in which the ability of S2 to block the 
binding of SI was measured, confirmed that the two antibodies had different 
affinities. 
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Once an RIA for the detection of SMV was defined, attention was turned 
to developing assay systems for MDMV-A and LMV. The MAI antibody had 
previously been tried in a double antibody technique which had been unsuc­
cessful. At the time, it was thought that the problem was due to numerous 
contaminating proteins in the antibody preparation, but after the results 
obtained with SI, it was reasoned that limited antigenic sites were prob­
ably the problem. Because the only other monoclonal antibody that bound to 
MDMV-A was L5 and that had proved unsuccessful as a capture antibody for 
SMV, it was decided to try another type of RIA in which only a single 
antibody would be needed. 
During the development of the RIA for SMV, a direct RIA had been used 
to confirm that tritiated SI did bind to SMV and to prove that SI and S2 
bound to different antigenic sites. This type of assay could be modified 
to an inhibition RIA for the detection of antigen using a single antibody. 
A procedure was developed in which tritiated antibody and the virus sample 
were incubated together before the addition of a virus coated bead. The 
amount of tritiated antibody that bound to the bead would be inversely 
proportional to the amount of virus in the sample. 
The inhibition technique proved to be very useful for developing 
detection assays that required only one type of monoclonal antibody. Gen­
erally after a few experiments to determine the optimum concentration of 
coating antigen and tritiated antibody, a successful assay was developed. 
Inhibition assays for the detection of LMV, MDMV-A, MDMV-B, and SMV were 
sensitive to the 10-50 ng range. Further work demonstrated that although 
the inhibition assay was affected by the presence of ground soybean seed, 
the sensitivity and quantitative relationship were maintained. 
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The attempt at binding MAI antibody covalently to a solid phase 
support resulted in Inactivation of the antibody. Both of the solid phase 
supports tried bind protein primarily at lysine residues; therefore, it may 
be that MAI has a lysine residue in its active site and covalent binding at 
the residue results in inactivation. The use of protein A to immobilize 
the antibody proved to be a useful way to remove virus particles from 
solution; however, infective virus could not be recovered. The loss of 
viral infectivity was probably due to subunit disassociation caused by the 
low pH of the eluting buffer. It is also possible, however, that the MAI 
antibody that eluted along with the virus caused viral neutralization by 
binding with the virus particles. 
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